Esteemed global frontrunner, making a worldwide impact through providing durable services and inventive outcomes to enhance the therapies and livelihoods of individuals with blood cancer. The goal is to enhance the treatment and lives of patients with leukaemia, lymphoma, and other haematological malignancies by progressing 'cutting-edge' clinical trials in Australasia. Aspire to be recognized by the local and international community as the foremost research body for these diseases within our operational and influential geographical areas.
Australasian Lymphoma and Leukaemia Group
Headquarters
Australia